Eyepoint Pharma (EYPT)
NASDAQ:EYPT
Want to see EYPT full AI Analyst Report?
EyePoint Pharmaceuticals (EYPT) Ownership Overview
10.76% Insiders
19.61% Mutual Funds
50.08% Other Institutional Investors
11.63% ETFs
7.91% Public Companies and
Individual Investors
The ownership structure of EyePoint Pharmaceuticals (EYPT) stock is a mix of institutional, retail, and individual investors. Approximately 81.32% of the company’s stock is owned by Institutional Investors, 10.76% is owned by Insiders, and 7.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 20, 2026 | xxxxxxxxxxxxx | $36555 | |
Mar 16, 2026 | xxxxxxxxxxxxx | $19710 | |
Mar 05, 2026 | xxxxxxxxxxxxx | $43567 | |
Feb 18, 2026 | xxxxxxxxxxxxx | $36555 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,265,000 | Insider | 9.86% | 112,899,900 | |
| 4,768,135 | Institution | 5.69% | 65,132,724 | |
| 4,254,281 | Institution | 5.07% | 58,113,478 | |
| 3,471,505 | Institution | 4.14% | 47,420,758 | |
| 3,312,589 | Institution | 3.95% | 45,249,966 | |
| 2,630,246 | Institution | 3.14% | 35,929,160 | |
| 1,245,583 | Institution | 1.49% | 17,014,664 | |
| 874,914 | Institution | 1.04% | 11,951,325 | |
| 800,790 | Institution | 0.96% | 10,938,791 | |
| 643,234 | Institution | 0.77% | 8,786,576 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,768,135 | Institution | 5.69% | 65,132,724 | |
| 3,471,505 | Institution | 4.14% | 47,420,758 | |
| 2,630,246 | Institution | 3.14% | 35,929,160 | |
| 1,245,583 | Institution | 1.49% | 17,014,664 | |
| 874,914 | Institution | 1.04% | 11,951,325 | |
| 800,790 | Institution | 0.96% | 10,938,791 | |
| 621,538 | Institution | 0.74% | 8,490,209 | |
| 436,197 | Institution | 0.52% | 5,958,451 | |
| 260,814 | Institution | 0.31% | 3,562,719 | |
| 244,414 | Institution | 0.29% | 3,338,695 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,600,860 | Institution | 3.10% | 35,319,679 | |
| 1,812,988 | Institution | 2.16% | 26,107,027 | |
| 880,623 | Institution | 1.05% | 11,958,860 | |
| 678,574 | Institution | 0.81% | 9,771,466 | |
| 484,996 | Institution | 0.58% | 6,974,242 | |
| 398,338 | Institution | 0.48% | 5,409,430 | |
| 378,301 | Institution | 0.45% | 5,439,968 | |
| 358,485 | Institution | 0.43% | 5,162,184 | |
| 212,769 | Institution | 0.25% | 2,889,403 | |
| 208,145 | Institution | 0.25% | 2,993,125 |
FAQ
Who Owns Eyepoint Pharma (EYPT)?
According to the latest TipRanks data, approximately 50.08% of the company's stock is held by institutional investors, 10.76% is held by insiders, and 7.91% is held by retail investors.
What percentage of Eyepoint Pharma (EYPT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.08% of Eyepoint Pharma (EYPT) stock is held by institutional investors.
What percentage of Eyepoint Pharma (EYPT) stock is held by retail investors?
According to the latest TipRanks data, approximately 7.91% of Eyepoint Pharma (EYPT) stock is held by retail investors.
Who owns the most shares of Eyepoint Pharma (EYPT)?
Cormorant Asset Management, LLC owns the most shares of Eyepoint Pharma (EYPT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.